MarketInOut Stock Screener Log In | Sign Up

Cutia Therapeutics

HKSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Cutia Therapeutics stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization261.19 mln
Float118 mln
Earnings Date03/30/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.02
Caution advised

1-Year Forecast

7.73
Transformational upside

Relative Strength

85 / 100
Strongly outperforming

Debt / Equity

0.39
Low leverage

Pre-Tax Margin

-85%
Severely loss-making

Business Description

Cutia Therapeutics is a China-based company focused on developing and commercializing treatments for skin and scalp conditions, including hair loss, acne, and localized fat reduction. Its product lineup spans topical sprays, foams, creams, and ointments, with several candidates already in or through clinical trials. The company also operates CATAME, a proprietary technology platform that supports the formulation and delivery of its growing range of products. Founded in 2019 and headquartered in Shanghai, Cutia serves markets across mainland China and Hong Kong.

Key Fundamentals

EPS-0.87
ROE-35.95
RPS1.08
ROIC-53.89
ROA-24.19
Interest Cover-29.68
EBITDA, mln-256
EV / EBITDA0.10
EV / EBIT0.09
Revenue, mln367

Quote Details

Last 0.69
Change -0.03 (-4.17%)
Open 0.715
Volume 85,000
Turnover 58,650
Average Volume 859,232

Financial Ratios

Pre-Tax Profit Margin-85
Leverage Ratio1.51
Current Ratio3.85
Price / Book0.45
Price / Tangible Book0.46
Debt / Equity0.39
Price / Sales1.02

Financial Strength

Altman Z-Score-3.33
Piotroski F-Score 5 / 9
Beneish M-Score-2.02
1-Year Target Price7.73

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.43% 49 / 100   
1 Month -37.27% 4 / 100   
2 Months -73.15% 1 / 100   
6 Months -85.03% 1 / 100   
1 Year -91.69% 1 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog